Clinical Trial Update: A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced Emphysema

View source ↗

Summary

The registry study evaluating the AeriSeal System for lung volume reduction in advanced emphysema/COPD has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• AeriSeal System

Snippet

Sponsor: Aeris Therapeutics | Conditions: Chronic Pulmonary Obstructive Disease, Emphysema | Status: TERMINATED